Clarins UV Plus HP SPF 40 Day Screen High Protection | Clarins UV Plus HP SPF 40 Day Screen High Protection
Active Ingredient PurposeTITANIUM DIOXIDE 8.1% Sunscreen
Uses:
- helps prevent sunburn
- higher SPF gives more sunburn protection
Warnings:
For external use only
When using this product:
- keep out of eyes. Rinse with water to remove
Stop use and ask a doctor if:
- rash or irritation develops and lasts
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
DIrections:
- apply liberally before sun exposure
- do not use on infants under 6 months age.
Other Information:
Sun alert: Limiting sun exposure, wearing protective clothing, and using sunscreens may reduce the risks of skin aging,skin cancer and other harmful effects of the sun.
Inactive Ingredients: CYCLOPENTASILOXANE - WATER - POLYGLYCERYL-3 POLYDIMETHYLSILOXYETHYL DIMETHICONE - CORN STATCH MODIFIED - ALCOHOL - ALUMINUM HYDROXIDE - STEARIC ACID - SODIUM CHLORIDE - PEG/PPG-18/18 DIMETHICONE - PHENOXYETHANOL - PEG/PPG-20/15 DIMETHICONE - TOCOPHERYL ACETATE - FRAGRANCE - HYDROXYPROPYLTRIMONIUM MALTODEEXTRIN CROSSPOLYMER - DISODIUM EDTA - BUTYLENE GLYCOL - GLYCERIN - PENTYLENE GLYCOL - CUCUMIS MELO (MELON) FRUIT EXTRACT - BIOSACCHARIDE GUM-4 - THERMUS THERMOPHILLUS FERMENT - LAPSANA COMMUNIS FLOWER/LEAF/STEM EXTRACT - CAMELLIA SINENSIS LEAF EXTRACT - POTASSIUM SORBATE - RHODIOLA ROSEA ROOT EXTRACT - SODIUM LAURYL SULFATE - BENZYL SALICYLATE - GERANIOL - CITRONELLOL - BENZYL BENZOATE - BUTYLPHENYL METHYLPROPIONAL - HYDROXYISOHEXYL 3-CYCLOHEXENE CARBOXALDEHYDE - LIMONENE - HEXYL CINNAMAL - LINALOOL.
Day Screen High Protection SPF 40 UVA-UVB/Oil-free
Triple protection against UVA-UVB rays, free radicals and pollution from an ultra-lightweight texture that leaves skin looking smooth, soft and matte. 100% mineral screen. Apply over regular day care.
Anti-oxidative stress. Formulated with an age-fighting antioxidant obtained from cantaloupe melon extract.
Allergy and ophthalmologist tested, non-comedogenic.
www.clarins.com
CLARINS PARIS - 92200 Neuilly France
95300 Pontoise
Made In France - Patent application
18 M ref. 12872 9
CLARINS PARIS
UV PLUS HP
Ecran Multi-Protection
SPF 40
Anti-pollution UVA-UVB/Oil-free
Day Screen High Protection
- Contains SPF 40 for high sun protection. Shake well before use. WARNINGS: for external use only. When using this product: keep out of eyes. Rinse with water to remove.Stop use and ask a doctor if rash or irritation develops and lasts.Keep out of reach of children. if swallowed, get medical help or contact a Poison Control Center immediately. Directions: apply liberally before sun exposure and as needed. Do not use on infants under 6 months of age.
ACTIVE INGREDIENTS: TITANIUM DIOXIDE 8.1 %.
18 M ref. 12872 9
CLARINS PARIS - 92200 Neuilly France
95300 Pontoise
Made in France
50 mL 1.7 Fl. Oz.
Manufacturer
Laboratoires Clarins S.A.
Active Ingredients
Source
- U.S. National Library of Medicine
- DailyMed
- Last Updated: 4 May 2013
Drugs and Medications
Clarins high protection sunscreen for sun-sensitive areas spf 30 [Laboratoires Clarins S.A.]
CLARINS HIGH PROTECTION SUNSCREEN STICK FOR SUN-SENSITIVE AREAS SPF 30
Clarins high protection sunscreen care milk for children spf 50 [Laboratoires Clarins S.A.]
CLARINS HIGH PROTECTION SUNSCREEN CARE MILK FOR CHILDREN SPF 50
Clarins men uv protection spf 40 [Laboratoires Clarins S.A]
CLARINS MEN UV Protection Oil-Free SPF 40
Clarins sunscreen for eyes wrinkle control spf 30 uva/uvb [Laboratoires Clarins S.A.]
Clarins Sunscreen For Eyes Wrinkle Control Cream SPF 30 UVA/UVB
Clarins uv plus hp dayscreen high protection tint - light spf 40 [Laboratoires Clarins S.A]
Clarins UV Plus HP Dayscreen High Protection Tint - Light SPF 40
Clinical Trials
Screen and Treat for Cervical Cancer Prevention
The study measures the impact of "screen–and-treat" on the prevalence of high-grade cervical intraepithelial neoplasia and cancer (CIN 2+). It is a three-arm, randomized clinical trial c...
EPIC US Feasibility Study: Use of the FiberNet® Emboli Protection Device in Carotid Artery Stenting
Multicenter, prospective, feasibility study designed to demonstrate the performance and safety of the Lumen Biomedical, Inc. FiberNet™ Embolic Protection System as an adjunctive device d...
The purpose of this study is to determine whether morbidity and mortality for high-risk surgical patients treated with the Carotid Wallstent in conjunction with the FilterWire EX and EZ Sy...
Proximal Protection With The MO.MA Device During Carotid Stenting
The objective of the ARMOUR study is to evaluate the safety and effectiveness of the Mo.Ma proximal flow blockage cerebral protection device for patients at high surgical risk for carotid...
Media Use in Preschooler Study (MUPS)
Childhood obesity is an epidemic and increasing. There are very few effective treatments for obesity in children. Recent studies have shown an association between obesity and sedentary b...
PubMed Articles
School-Based Screening for Suicide Risk: Balancing Costs and Benefits.
Objectives. We examined the effects of a scoring algorithm change on the burden and sensitivity of a screen for adolescent suicide risk. Methods. The Columbia Suicide Screen was used to screen 641 hig...
Batch fabrication of disposable screen printed SERS arrays.
A novel facile method of fabricating disposable and highly reproducible surface-enhanced Raman spectroscopy (SERS) arrays using screen printing was explored. The screen printing ink containing silver...
Hepatitis B virus screening before chemotherapy for lymphoma: a cost-effectiveness analysis.
PURPOSE Hepatitis B virus (HBV) reactivation is a potentially fatal complication of chemotherapy that can be largely prevented with antiviral prophylaxis. It remains unclear whether HBV screening is c...
Staff Radiation Doses in a Real-Time Display Inside the Angiography Room.
METHODS: The evaluation of a new occupational Dose Aware System (DAS) showing staff radiation doses in real time has been carried out in several angiography rooms in our hospital. The system uses elec...
The aim of this study was to examine the independent relationships of television viewing or other screen-based entertainment ("screen time") with all-cause mortality and clinically confirmed cardiovas...
